Gene: TMEM38B
Official Full Name: transmembrane protein 38Bprovided by HGNC
Gene Summary: This gene encodes an intracellular monovalent cation channel that functions in maintenance of intracellular calcium release. Mutations in this gene may be associated with autosomal recessive osteogenesis. [provided by RefSeq, Oct 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13332 | TMEM38B Knockout cell line (HeLa) | Human | TMEM38B | 1:3~1:6 | Negative | Online Inquiry |
KO13333 | TMEM38B Knockout cell line (HCT 116) | Human | TMEM38B | 1:2~1:4 | Negative | Online Inquiry |
KO13334 | TMEM38B Knockout cell line (HEK293) | Human | TMEM38B | 1:3~1:6 | Negative | Online Inquiry |
KO13335 | TMEM38B Knockout cell line (A549) | Human | TMEM38B | 1:3~1:4 | Negative | Online Inquiry |
TMEM38B Gene Knockout Cell Lines are genetically engineered cell lines in which the TMEM38B gene has been inactivated or deleted, providing researchers with a powerful tool to study the gene's role in cellular processes. The TMEM38B gene encodes a membrane protein that has been implicated in calcium homeostasis and signal transduction, functioning as an ion channel that is critical for various physiological processes. By utilizing these knockout cell lines, scientists can investigate the downstream effects of TMEM38B deficiency on cellular signaling pathways, ion transport mechanisms, and gene expression patterns.
The primary mechanism of these knockout cell lines involves CRISPR-Cas9 technology, which allows for precise editing of the genome, resulting in a loss-of-function phenotype of the TMEM38B gene. Such models are invaluable for exploring the implications of TMEM38B in diseases such as cancer, neurological disorders, and cellular response to stress. By understanding how the absence of TMEM38B affects cell behavior, researchers can uncover potential therapeutic targets and biomarkers.
These TMEM38B Gene Knockout Cell Lines stand out due to their high specificity and reliability compared to alternative methods such as RNA interference or conventional gene knockout approaches. They offer consistent performance and reproducibility, essential factors for robust experimental design. Additionally, the availability of well-characterized cell lines accelerates research timelines, enabling scientists to focus on data generation rather than labor-intensive genetic manipulation.
For researchers and clinicians focused on cellular biology, pharmacology, or therapeutic development, the TMEM38B Gene Knockout Cell Lines provide a unique opportunity to generate insightful data that could lead to significant advancements in understanding cellular function and disease mechanisms. With a deep commitment to quality and innovation, our company specializes in the development and supply of cutting-edge biological products tailored to meet the needs of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.